Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble
Seeking Alpha
Friday, September 6, 2013 - 10:31am
tags:
Teva, Rexahn, RX-3117
Updated Vascepa Data And Why I Would Buy Into Amarin's Current Momentum
Seeking Alpha
Friday, September 6, 2013 - 10:29am
tags:
Vascepa, Amarin
Mallinckrodt's extended-release pain drug meets main goal of study
Reuters
Friday, September 6, 2013 - 10:25am
tags:
Mallinckrodt, MNK-795
Glaxo-Theravance Lung Drug Shows Strong Efficacy, FDA Say
Bloomberg
Friday, September 6, 2013 - 10:16am
tags:
GSK, Theravance, COPD, Anoro Ellipta
Merck poised for expansion of Zostavax shingles vax as demand grows
Fierce Pharma
Friday, September 6, 2013 - 9:17am
tags:
Zostavax, vaccines, shingles, Merck
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Friday, September 6, 2013 - 9:12am
tags:
Incyte, JAK inhibitors, Jakafi, myelofibrosis
Biogen may be capturing 50% of new MS patients, says Cowen
Yahoo/Fly on the Wall
Friday, September 6, 2013 - 8:58am
tags:
MS, Biogen Idec, multiple sclerosis, Tecfidera
Endo Health says FDA agreed to review its application for the testosterone injection Aveed
Yahoo/AP
Friday, September 6, 2013 - 8:57am
tags:
FDA, Endo Health Solutions, testosterone, Aveed
Novartis announces global licensing, research collaboration with Regenerex
Yahoo/Fly on the Wall
Friday, September 6, 2013 - 8:21am
tags:
Novartis, Regeneron, R&D, liscensing
Pfizer Looks Good Despite Disappointing Eliquis Sales
Seeking Alpha
Friday, September 6, 2013 - 8:20am
tags:
Pfizer, Merck, Bristol-Myers Squibb, Eliquis, DVT, bloodthinners
4 Healthcare Stock Stories Making Sector Headlines Thursday
Wall St. Cheat Sheet
Thursday, September 5, 2013 - 6:54pm
tags:
Celgene, MM-003, AlaicBronchial Thermoplasty, Boston Scientific, Aveed, Endo Health Solutions, Neuralstem
Theravance says lung disease drug TD-4208 succeeded in a midstage clinical trial
Yahoo/AP
Thursday, September 5, 2013 - 6:51pm
tags:
Theravance, TD-4208, COPD
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thursday, September 5, 2013 - 6:50pm
tags:
JNJ, Forest Labs, Pfizer, Novartis, Ironwood Pharmaceuticals
MacroGenics trumpets cancer immunotherapies in $60M IPO pitch
Fierce Biotech
Thursday, September 5, 2013 - 8:56am
tags:
Macrogenics, cancer immunotherapy, IPOs
Can GlaxoSmithKline Get Past Recent Headlines?
Wall St. Cheat Sheet
Thursday, September 5, 2013 - 8:51am
tags:
GSK
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thursday, September 5, 2013 - 8:50am
tags:
Merck, Alzheimer's disease, Pfizer, Eli Lilly, JNJ, bapineuzumab, solanezumab, BACE inhibitors, MK-8931
False Claims, Off-Label Prescribing And Doctors, Part Two
Pharmalot
Thursday, September 5, 2013 - 8:45am
tags:
off-label, physicians, False Claims Act
Celgene says phase III study of pomalidomide combo met primary endpoint
Yahoo/Fly on the Wall
Thursday, September 5, 2013 - 8:26am
tags:
Celgene, pomalidomide, Multiple Myeloma
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thursday, September 5, 2013 - 8:24am
tags:
Novo Nordisk, diabetes
Amarin Regains Ahead Of Vital Q4 Catalysts
Seeking Alpha
Thursday, September 5, 2013 - 8:23am
tags:
Amarin, Vascepa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.